vs

Side-by-side financial comparison of MARCHEX INC (MCHX) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.

MARCHEX INC is the larger business by last-quarter revenue ($10.8M vs $6.8M, roughly 1.6× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -21.4%, a 29.1% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -9.0%). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -3.2%).

Marchex Inc. is a U.S.-headquartered technology company focused on conversational analytics, call tracking, and digital marketing solutions for small and medium-sized businesses as well as enterprise clients across North America. Its core products help businesses optimize customer acquisition strategies, quantify marketing campaign performance, and improve customer engagement across voice and digital communication channels.

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

MCHX vs PRPO — Head-to-Head

Bigger by revenue
MCHX
MCHX
1.6× larger
MCHX
$10.8M
$6.8M
PRPO
Growing faster (revenue YoY)
PRPO
PRPO
+37.4% gap
PRPO
28.4%
-9.0%
MCHX
Higher net margin
PRPO
PRPO
29.1% more per $
PRPO
7.7%
-21.4%
MCHX
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
-3.2%
MCHX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCHX
MCHX
PRPO
PRPO
Revenue
$10.8M
$6.8M
Net Profit
$-2.3M
$526.0K
Gross Margin
61.6%
45.9%
Operating Margin
-21.9%
7.9%
Net Margin
-21.4%
7.7%
Revenue YoY
-9.0%
28.4%
Net Profit YoY
-21.3%
244.1%
EPS (diluted)
$-0.05
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCHX
MCHX
PRPO
PRPO
Q4 25
$10.8M
$6.8M
Q3 25
$11.5M
$6.9M
Q2 25
$11.7M
$5.6M
Q1 25
$11.4M
$4.9M
Q4 24
$11.9M
$5.3M
Q3 24
$12.6M
$5.3M
Q2 24
$12.1M
$4.5M
Q1 24
$11.6M
$3.5M
Net Profit
MCHX
MCHX
PRPO
PRPO
Q4 25
$-2.3M
$526.0K
Q3 25
$-1.0M
$-79.0K
Q2 25
$84.0K
$74.0K
Q1 25
$-2.0M
$-884.0K
Q4 24
$-1.9M
$-365.0K
Q3 24
$-831.0K
$-626.0K
Q2 24
$-756.0K
$-1.2M
Q1 24
$-1.4M
$-2.1M
Gross Margin
MCHX
MCHX
PRPO
PRPO
Q4 25
61.6%
45.9%
Q3 25
63.1%
43.6%
Q2 25
65.1%
43.2%
Q1 25
63.3%
43.6%
Q4 24
63.2%
49.8%
Q3 24
66.4%
43.1%
Q2 24
65.6%
38.1%
Q1 24
61.9%
26.5%
Operating Margin
MCHX
MCHX
PRPO
PRPO
Q4 25
-21.9%
7.9%
Q3 25
-8.2%
-0.9%
Q2 25
-4.6%
-14.6%
Q1 25
-16.4%
-17.5%
Q4 24
-13.3%
-6.3%
Q3 24
-6.6%
-11.3%
Q2 24
-6.0%
-26.8%
Q1 24
-11.3%
-59.6%
Net Margin
MCHX
MCHX
PRPO
PRPO
Q4 25
-21.4%
7.7%
Q3 25
-8.9%
-1.1%
Q2 25
0.7%
1.3%
Q1 25
-17.4%
-18.0%
Q4 24
-16.0%
-6.9%
Q3 24
-6.6%
-11.9%
Q2 24
-6.3%
-27.1%
Q1 24
-12.5%
-59.8%
EPS (diluted)
MCHX
MCHX
PRPO
PRPO
Q4 25
$-0.05
$0.36
Q3 25
$-0.02
$-0.05
Q2 25
$0.00
$0.05
Q1 25
$-0.05
$-0.59
Q4 24
$-0.04
$-0.22
Q3 24
$-0.02
$-0.42
Q2 24
$-0.02
$-0.83
Q1 24
$-0.03
$-1.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCHX
MCHX
PRPO
PRPO
Cash + ST InvestmentsLiquidity on hand
$9.9M
$2.7M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$30.1M
$14.6M
Total Assets
$39.7M
$21.3M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCHX
MCHX
PRPO
PRPO
Q4 25
$9.9M
$2.7M
Q3 25
$10.3M
$2.3M
Q2 25
$10.5M
$1.1M
Q1 25
$10.0M
$1.0M
Q4 24
$12.8M
$1.4M
Q3 24
$12.1M
$1.1M
Q2 24
$12.0M
$1.3M
Q1 24
$12.0M
$776.0K
Total Debt
MCHX
MCHX
PRPO
PRPO
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MCHX
MCHX
PRPO
PRPO
Q4 25
$30.1M
$14.6M
Q3 25
$31.9M
$13.7M
Q2 25
$32.0M
$12.3M
Q1 25
$31.4M
$11.7M
Q4 24
$32.6M
$12.1M
Q3 24
$34.1M
$11.9M
Q2 24
$34.5M
$12.1M
Q1 24
$34.9M
$12.8M
Total Assets
MCHX
MCHX
PRPO
PRPO
Q4 25
$39.7M
$21.3M
Q3 25
$41.1M
$21.2M
Q2 25
$42.0M
$18.8M
Q1 25
$40.6M
$17.8M
Q4 24
$43.2M
$17.0M
Q3 24
$44.1M
$17.0M
Q2 24
$45.5M
$17.3M
Q1 24
$45.6M
$16.6M
Debt / Equity
MCHX
MCHX
PRPO
PRPO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCHX
MCHX
PRPO
PRPO
Operating Cash FlowLast quarter
$121.0K
$366.0K
Free Cash FlowOCF − Capex
$291.0K
FCF MarginFCF / Revenue
4.3%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$359.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCHX
MCHX
PRPO
PRPO
Q4 25
$121.0K
$366.0K
Q3 25
$290.0K
$10.0K
Q2 25
$803.0K
$353.0K
Q1 25
$-2.6M
$-44.0K
Q4 24
$875.0K
$565.0K
Q3 24
$382.0K
$41.0K
Q2 24
$117.0K
$500.0K
Q1 24
$-2.5M
$-667.0K
Free Cash Flow
MCHX
MCHX
PRPO
PRPO
Q4 25
$291.0K
Q3 25
$-44.0K
Q2 25
$294.0K
Q1 25
$-182.0K
Q4 24
$757.0K
Q3 24
$199.0K
$-68.0K
Q2 24
$40.0K
Q1 24
$-2.5M
FCF Margin
MCHX
MCHX
PRPO
PRPO
Q4 25
4.3%
Q3 25
-0.6%
Q2 25
5.2%
Q1 25
-3.7%
Q4 24
6.3%
Q3 24
1.6%
-1.3%
Q2 24
0.3%
Q1 24
-21.4%
Capex Intensity
MCHX
MCHX
PRPO
PRPO
Q4 25
1.1%
Q3 25
0.0%
0.8%
Q2 25
1.0%
Q1 25
2.8%
Q4 24
1.0%
Q3 24
1.5%
2.1%
Q2 24
0.6%
Q1 24
0.0%
Cash Conversion
MCHX
MCHX
PRPO
PRPO
Q4 25
0.70×
Q3 25
Q2 25
9.56×
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons